Celltrion's Yuflyma to Accelerate Prescription Growth with Costco Sale

Reporter Kim Jisun / approved : 2024-08-14 03:32:54
  • -
  • +
  • 인쇄

Seo Jung-jin, honorary chairman of Celltrion (photo= Celltrion)

 

[Alpha Biz= Reporter Kim Jisun] Celltrion's Yuflyma to Accelerate Prescription Growth with Costco Sale

Celltrion announced on August 13 that its self-immune disorder treatment, Yuflyma (ingredient: adalimumab), is now available for purchase at Costco, a major U.S. retailer. The drug was registered with the Costco Member Prescription Program (CMPP) as of August 1 (local time).

The CMPP allows Costco members to buy medications at discounted prices from in-store or affiliated pharmacies. Starting this month, uninsured Costco members and their dependents can purchase Low WAC Yuflyma at a reduced price from Costco stores and partner pharmacies across the U.S.

 

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Bomb Threats Target Major Korean Companies Including Samsung Electronics2025.12.19
FSS Raises Consumer Alert to “Warning” Over Secondary Scams Linked to Coupang Data Breach2025.12.19
Final U.S. Defense Authorization Bill Omits Provisions Supporting South Korea-Japan Shipbuilding Cooperation2025.12.19
Controversy Surrounds KT’s Former Outside Director Cho Seung-ah Amid Dual Directorship Issue2025.12.19
Samsung Securities Lowers LG Energy Solution Target Price to KRW 480,000 Amid Contract Cancellations2025.12.19
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사